Welcome to my New Blog... Graphs Tables for Skin Cancer

Skin Cancer, mesothelioma, Mesothelioma Cancer, Mesothelioma Lwayer
=======================================================

Friday, August 1, 2008

Fwd: Disruption of arginase II alters prostate tumor formation in TRAMP mice.



---------- Forwarded message ----------
From: HubMed - cancer <rssfwd@rssfwd.com>
Date: Wed, Jul 30, 2008 at 9:30 PM
Subject: Disruption of arginase II alters prostate tumor formation in TRAMP mice.
To: mesothelioma77@gmail.com


[1]Prostate. 2008 Jul 28;
Mumenthaler SM, Rozengurt N, Livesay JC, Sabaghian A, Cederbaum SD, Grody WW

BACKGROUND: Arginase II (AII) is involved in the polyamine synthetic pathway, and elevated levels of expression have been found in a high proportion of prostate cancer samples and patients. However, the biological function of arginase II in prostate cancer still remains to be elucidated. In this study, we utilized the TRAMP mouse prostate cancer model to better understand the contribution of AII on tumor development. METHODS: AII expression was determined in prostates from TRAMP mice at 23 weeks of age by real-time RT-PCR and Western blot analysis. Additionally, AII expression was disrupted in the TRAMP model by crossbreeding arginase II knockout (AII KO) mice with TRAMP mice in order to generate the TRAMP/AII KO line. In each group, genito-urinary (GU) tract weights were determined and a pathological evaluation of the tumors was completed. RESULTS: AII expression was only detectable in those mice without the presence of macroscopic tumors; it was also absent in the TRAMP-C2 cell line, which is characteristic of an advanced prostate tumor. Assessment of the GU weights revealed larger average GU weights in the TRAMP/AII KO mice compared to TRAMP mice. Additionally, a greater percentage of more advanced pathology was found in the TRAMP/AII KO group compared to the TRAMP cohort. CONCLUSIONS: Based on these results, AII deficiency in the TRAMP model seems to accelerate prostate tumor progression, leading to an overall more advanced cancer stage in these mice. These findings support the possibility that prostatic arginase II could be a potentially useful marker of disease progression. Prostate (c) 2008 Wiley-Liss, Inc.



___
Source: http://www.hubmed.org/display.cgi?uids=18663728
--
 
~
Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 http://www.aseanface.com/display_blog.php
 
 
Links for Aseanface Humor
 
 

Fwd: Disparities in Urban and Rural Mastectomy Populations : The Effects of Patient- and County-Level Factors on Likelihood of Receipt of Mastectomy.



---------- Forwarded message ----------
From: HubMed - breast cancer <rssfwd@rssfwd.com>
Date: Wed, Jul 30, 2008 at 9:30 PM
Subject: Disparities in Urban and Rural Mastectomy Populations : The Effects of Patient- and County-Level Factors on Likelihood of Receipt of Mastectomy.
To: mesothelioma77@gmail.com


[1]Ann Surg Oncol. 2008 Jul 29;
Jacobs LK, Kelley KA, Rosson GD, Detrani ME, Chang DC

BACKGROUND: Using the 2006 Surveillance, Epidemiology, and End Results (SEER) database and the 2004 Area Resource File (ARF), the likelihood of mastectomy for stages I-III breast cancer patients in urban versus rural populations are examined. County and patient level data are evaluated for impact on receipt of mastectomy. Patient variables included age, stage, race, and marital status, and community variables are income, employment, and radiation facility staff density. The likelihood of mastectomy in urban and rural patients, and the impact of the different variables on that procedure, is reported. METHODS: This retrospective analysis of a combined dataset from the 2006 SEER database and the 2004 ARF linked using the federal information processing standard (FIPS) state county variable evaluates patient and county variables with multivariate regression. RESULTS: From 1992 to 2003, 137,303 patients were identified in the SEER database. The rural population (county population of

___
Source: http://www.hubmed.org/display.cgi?uids=18663535
--
 ~
Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc